TOPOGRAPHICAL MAPPING OF 436 NEWLY DIAGNOSED IDH WILDTYPE GLIOBLASTOMA WITH VS. WITHOUT MGMT PROMOTER METHYLATION

Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation

Introduction: O6-methylguanine-methyltransferase (MGMT) promoter methylation and isocitrate dehydrogenase (IDH) mutation status are important prognostic factors for patients with glioblastoma.There are conflicting reports about a differential topographical distribution of glioblastoma with vs.without MGMT promoter methylation, possibly caused by mo

read more